Jean C. Nault
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Atezolizumab-bevacizumab in very elderly with hepatocellular carcinoma: Age alone is not a limiting factor except in ALBI grade 3.
Journal: JHEP reports : innovation in hepatology
Published: February 16, 2026
Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 14, 2026
Second-line TKI after first-line immunotherapy-based treatment in advanced HCC: Reconstructed IPD meta-analysis.
Journal: JHEP reports : innovation in hepatology
Published: December 16, 2025
Detection of esophageal varices and prediction of hepatic decompensation in unresectable hepatocellular carcinoma using AI.
Journal: Journal of hepatology
Published: October 10, 2025
Detection of Esophageal Varices and Prediction of Hepatic Decompensation in Unresectable Hepatocellular Carcinoma using AI: AI Detection of Varices and Decompensation.
Journal: Journal of hepatology
Published: October 10, 2025
Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort study.
Journal: Hepatology international
Published: June 17, 2025
Early Hemostatic Treatment Could Improve 30-Day Survival After Spontaneous Rupture of Hepatocellular Carcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 07, 2025
Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: December 01, 2023
Upfront multi-bipolar radiofrequency ablation for HCC in transplant-eligible cirrhotic patients with salvage transplantation in case of recurrence.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 03, 2023
Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC.
Journal: Clinics and research in hepatology and gastroenterology
Published: August 08, 2023
Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: A multicentric retrospective study.
Journal: United European gastroenterology journal
Published: July 28, 2023
Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 02, 2021
Last Updated: 09/26/2026